SHABANA MOHAMMAD ALI. Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients. Pakistan Journal of Medical & Health Sciences, [S. l.], v. 18, n. 01, p. 35, 2024. DOI: 10.53350/pjmhs0202418135. Disponível em: https://pjmhsonline.com/index.php/pjmhs/article/view/5440. Acesso em: 27 jul. 2024.